Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Consolidation Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01145209
What this trial is testing

Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL

Who this might be right for
Small Lymphocytic LymphomaCLL (Chronic Lymphocytic Leukemia)
National Heart, Lung, and Blood Institute (NHLBI) 32
Testing effectiveness (Phase 2)Study completedNCT03677154
What this trial is testing

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Hoffmann-La Roche 188
Testing effectiveness (Phase 2)Study completedNCT03285321
What this trial is testing

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Greg Durm, MD 105
Testing effectiveness (Phase 2)UnknownNCT05334693
What this trial is testing

Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 15
Early research (Phase 1)Study completedNCT04951063
What this trial is testing

Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC

Who this might be right for
Locally Advanced Lung Carcinoma
Sun Yat-sen University 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03391869
What this trial is testing

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
M.D. Anderson Cancer Center 339
Testing effectiveness (Phase 2)Study completedNCT04212598
What this trial is testing

The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Wuhan University 40
Large-scale testing (Phase 3)Looking for participantsNCT04585490
What this trial is testing

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

Who this might be right for
Non Small Cell Lung CancerNSCLC, Stage IIINsclc
Maximilian Diehn 48
Testing effectiveness (Phase 2)Looking for participantsNCT06187597
What this trial is testing

Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 140
Testing effectiveness (Phase 2)Study completedNCT01183416
What this trial is testing

High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT07321301
What this trial is testing

Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia

Who this might be right for
B-cell Lymphoma Refractory
Daihong Liu 10
Large-scale testing (Phase 3)Ended earlyNCT00050375
What this trial is testing

Clinical Trial for Ovarian Cancer (OvaRex®)

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 354
Testing effectiveness (Phase 2)Study completedNCT01734304
What this trial is testing

DC Vaccination for Postremission Therapy in AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 13
Testing effectiveness (Phase 2)Looking for participantsNCT07014202
What this trial is testing

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 224
Not applicableNo Longer AvailableNCT04501757
What this trial is testing

Naxitamab and GM-CSF in People With Neuroblastoma

Who this might be right for
High-Risk Neuroblastoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04231552
What this trial is testing

Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Very early researchStudy completedNCT04188951
What this trial is testing

HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Henry Ford Health System 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07094477
What this trial is testing

Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma

Who this might be right for
Lymphoma
Daihong Liu 50
Testing effectiveness (Phase 2)Looking for participantsNCT07779018
What this trial is testing

CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy

Who this might be right for
Lymphoma
Liping Dou 30
Large-scale testing (Phase 3)Looking for participantsNCT05623267
What this trial is testing

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Who this might be right for
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University 346
Next Page